iBio Inc.


Recent Releases, Events & Media Assets


Latest News

Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action

NEW YORK, NY -- (Marketwired) -- 01/27/17 -- iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider approval of a settlement of the derivative action captioned Spencer Savage and Yousef Barakat,

Read Press Release

Latest Presentation

Upcoming Event

Dr. Carol Fengali-Bostwick presents at the Scleroderma Foundation – Courtesy of the Scleroderma Foundation, Inc.

Learn More